BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3246246)

  • 1. Effects of intracoronary infusion of nicardipine during silent ischaemia on myocardial metabolism and function.
    Hanet C; Gurné O; Hue L; Caucheteux D; Rousseau MF; Pouleur H
    Eur Heart J; 1988 Dec; 9 Suppl N():145-50. PubMed ID: 3246246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and hemodynamic effects of nicardipine during pacing-induced angina pectoris.
    Thomassen A; Bagger JP; Nielsen TT; Henningsen P
    Am J Cardiol; 1987 Feb; 59(4):219-24. PubMed ID: 3812268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine.
    Rousseau MF; Hanet C; Pardonge-Lavenne E; Van den Berghe G; Van Hoof F; Pouleur H
    Circulation; 1986 Jun; 73(6):1270-80. PubMed ID: 3698257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy.
    Hanet C; Pouleur H; Harlow BJ; Rousseau MF
    Am Heart J; 1988 Aug; 116(2 Pt 1):431-9. PubMed ID: 3041788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris.
    Rousseau MF; Vincent MF; Van Hoof F; Van den Berghe G; Charlier AA; Pouleur H
    Am J Cardiol; 1984 Dec; 54(10):1189-94. PubMed ID: 6507289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.
    Rousseau MF; Vincent MF; Cheron P; van den Berghe G; Charlier AA; Pouleur H
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):147S-157S. PubMed ID: 2862900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris.
    Lambert CR; Hill JA; Feldman RL; Pepine CJ
    Am J Cardiol; 1987 Sep; 60(7):471-6. PubMed ID: 3630928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved myocardial lactate extraction after propranolol in coronary artery disease: effected by peripheral glutamate and free fatty acid metabolism.
    Nielsen TT; Bagger JP; Thomassen A
    Br Heart J; 1986 Feb; 55(2):140-7. PubMed ID: 3942648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic and coronary hemodynamic effects of intravenous nicardipine at rest and in ischemia induced by rapid atrial stimulation].
    Berland J; Savin T; Saoudi N; Cribier A; Letac B
    Arch Mal Coeur Vaiss; 1987 Sep; 80(10):1513-21. PubMed ID: 3125811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty.
    Hanet C; Rousseau MF; Vincent MF; Lavenne-Pardonge E; Pouleur H
    Am J Cardiol; 1987 May; 59(12):1035-40. PubMed ID: 2953226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nicardipine on left ventricular function and energetics in man.
    Lambert CR; Hill JA; Feldman RL; Pepine CJ
    Int J Cardiol; 1986 Mar; 10(3):237-50. PubMed ID: 3957469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased coronary sinus lactate concentration during pacing induced angina pectoris after clinical improvement by glyceryl trinitrate.
    Bagger JP; Nielsen TT; Henningsen P
    Br Heart J; 1983 Nov; 50(5):483-90. PubMed ID: 6416279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved myocardial contractility with glucose-insulin-potassium infusion during pacing in coronary artery disease.
    McDaniel HG; Rogers WJ; Russell RO; Rackley CE
    Am J Cardiol; 1985 Apr; 55(8):932-6. PubMed ID: 3885708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate release during the recovery period of pacing-induced angina in assessment of myocardial ischaemia.
    Cuccurullo F; Mezzetti A; Tomassetti V; Porreca E; Guglielmi MD; Pasquale M; Lapenna D; Marzio L; Poggiopollini G; Lenzi S
    Eur Heart J; 1986 Jan; 7(1):77-85. PubMed ID: 3956525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianginal and cardiac metabolic effects of low-dose glucose infusion during pacing in patients with and without coronary artery disease.
    Thomassen A; Nielsen TT; Bagger JP; Henningsen P
    Am Heart J; 1989 Jul; 118(1):25-32. PubMed ID: 2662729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial lactate metabolism during pacing induced angina pectoris.
    Ihlen H; Simonsen S; Thaulow E
    Scand J Clin Lab Invest; 1983 Feb; 43(1):1-7. PubMed ID: 6622963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered global myocardial substrate preference at rest and during pacing in coronary artery disease with stable angina pectoris.
    Thomassen A; Bagger JP; Nielsen TT; Henningsen P
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):686-93. PubMed ID: 3421165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action.
    Mannheimer C; Eliasson T; Andersson B; Bergh CH; Augustinsson LE; Emanuelsson H; Waagstein F
    BMJ; 1993 Aug; 307(6902):477-80. PubMed ID: 8400930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of verapamil on myocardial exchange of free fatty acids, citrate, lactate and glucose in coronary artery disease.
    Bagger JP; Nielsen TT; Henningsen P
    Eur Heart J; 1983 Jun; 4(6):406-14. PubMed ID: 6617687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic and metabolic effects of atenolol in patients with angina pectoris.
    Thompson DS; Naqvi N; Juul SM; Coltart DJ; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1980 Jun; 43(6):668-79. PubMed ID: 7426146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.